Middle East Pharmaceutical Industries Dividends and Buybacks
Dividend criteria checks 1/6
Middle East Pharmaceutical Industries is a dividend paying company with a current yield of 1.22% that is well covered by earnings.
Key information
1.2%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 1.2% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ر.س1.500 |
| Payout ratio | 19% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether 4016's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 4016's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| Middle East Pharmaceutical Industries Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4016) | 1.2% |
| Market Bottom 25% (SA) | 1.8% |
| Market Top 25% (SA) | 4.7% |
| Industry Average (Pharmaceuticals) | 1.8% |
| Analyst forecast (4016) (up to 3 years) | 1.2% |
Notable Dividend: 4016's dividend (1.22%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.85%).
High Dividend: 4016's dividend (1.22%) is low compared to the top 25% of dividend payers in the SA market (4.71%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (18.6%), 4016's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (93.1%), 4016's dividend payments are not well covered by cash flows.